Manhattan Scientifics, Inc. (MHTX)
OTCMKTS · Delayed Price · Currency is USD
0.0008
0.00 (0.00%)
Oct 4, 2024, 1:22 PM EDT

Manhattan Scientifics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Revenue
--0.050.050.050.1
Upgrade
Revenue Growth (YoY)
--0%0%-48.45%-
Upgrade
Gross Profit
--0.050.050.050.1
Upgrade
Selling, General & Admin
0.670.690.720.730.711.11
Upgrade
Research & Development
0.010.010.010.010.010.01
Upgrade
Operating Expenses
0.680.70.730.740.731.12
Upgrade
Operating Income
-0.68-0.7-0.68-0.69-0.68-1.03
Upgrade
Interest Expense
---0.02-0.03-0.03-0.01
Upgrade
EBT Excluding Unusual Items
-0.68-0.7-0.7-0.71-0.7-1.03
Upgrade
Gain (Loss) on Sale of Investments
-0.37-0.48-2.03-2.975.01-0.19
Upgrade
Other Unusual Items
-0.02-0.05--
Upgrade
Pretax Income
-1.06-1.17-2.73-3.644.31-1.22
Upgrade
Net Income
-1.06-1.17-2.73-3.644.31-1.22
Upgrade
Net Income to Common
-1.06-1.17-2.73-3.644.31-1.22
Upgrade
Shares Outstanding (Basic)
559559559559558549
Upgrade
Shares Outstanding (Diluted)
559559559559593549
Upgrade
Shares Change (YoY)
----5.69%7.95%2.92%
Upgrade
EPS (Basic)
-0.00-0.00-0.00-0.010.01-0.00
Upgrade
EPS (Diluted)
-0.00-0.00-0.00-0.010.01-0.00
Upgrade
Free Cash Flow
-0.11-0.19-0.35-0.42-0.39-0.32
Upgrade
Free Cash Flow Per Share
-0.00-0.00-0.00-0.00-0.00-0.00
Upgrade
Gross Margin
--100.00%100.00%100.00%100.00%
Upgrade
Operating Margin
---1358.00%-1374.00%-1350.00%-1056.70%
Upgrade
Profit Margin
---5460.00%-7278.00%8628.00%-1259.79%
Upgrade
Free Cash Flow Margin
---698.00%-842.00%-784.00%-325.77%
Upgrade
EBITDA
-0.68-0.7-0.68-0.69-0.67-1.02
Upgrade
D&A For EBITDA
000000
Upgrade
EBIT
-0.68-0.7-0.68-0.69-0.68-1.03
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.